Cornerstone Dermatology

Coorparoo, Queensland 4151

1 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Chronic Spontaneous Urticaria, Eczema

Studies at this site

• A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Enrolling by invitation
• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) — Running, not enrolling